Johnson & Johnson (JNJ)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
162.24+1.85 (+1.15%)
At close: 4:00PM EDT
| Previous close | 160.39 |
| Open | 161.34 |
| Bid | 162.29 x 1800 |
| Ask | 162.22 x 1200 |
| Day's range | 160.56 - 162.51 |
| 52-week range | 133.65 - 173.65 |
| Volume | 9,034,379 |
| Avg. volume | 8,189,491 |
| Market cap | 427.131B |
| Beta (5Y monthly) | 0.72 |
| PE ratio (TTM) | 29.44 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 4.04 (2.52%) |
| Ex-dividend date | 22 Feb 2021 |
| 1y target est | N/A |
- Editor's pickYahoo Finance Video
'You can think of it like an annual flu shot': Doctor on possible COVID-19 booster shots
Assistant Professor of Emergency Medicine at Baylor College of Medicine, Dr. Sara Andrabi, joined Yahoo Finance to break down her thoughts on the possibility of needing annual COVID-19 booster shots to.
- Editor's pickYahoo Finance Video
Doctor: COVID-19 vaccines 'do lead to a really strong immune response'
The CEO of Pfizer has warned that a third COVID-19 vaccine dose will likely be necessary within 12 months. Get Us PPE Co-Founder and Harvard Medical School Professor Dr. Ali Raja joins Yahoo Finance Live to discuss.
- Editor's pickYahoo Finance Video
Pfizer CEO says a third vaccine dose is likely, Moderna updates booster shot timeline
Pfizer CEO sees need for a third vaccine dose as Moderna updates its timeline on third booster shot. Pause on the Johnson & Johnson vaccine remains. Yahoo Finance’s Anjalee Khemlani breaks down the details.
© 2021 Verizon Media. All rights reserved.
